| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/06/1997 | EP0731794B1 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders |
| 08/06/1997 | EP0667774B1 Transdermal therapeutic system for administering physostigmin through the skin, and a method of producing the system |
| 08/06/1997 | EP0559825B1 Device for treating tobacco addiction |
| 08/06/1997 | EP0540757B1 Water-based recording ink |
| 08/06/1997 | CN1156454A N-substituted 3-azabicyclo(3,2,0) heptane derivatives and preparing method and use thereof |
| 08/06/1997 | CN1156451A Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 08/06/1997 | CN1156449A Dihygropyridine derivatives as bradykinin antagonists |
| 08/06/1997 | CN1156447A 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals |
| 08/06/1997 | CN1156400A Subcutaneous implant |
| 08/06/1997 | CN1156147A Novel tetracylic 1,4-oxazine compound, its preparing method and medicinal composition containing same |
| 08/06/1997 | CN1156036A Oral liquor for curing and regulating heart, spleen and kidney functions |
| 08/06/1997 | CN1035552C Branched alkylamino derivatives of thiazole, processes for preparing them and pharmaceutical compositions containing them |
| 08/05/1997 | US5654445 Intermediates for renin inhibitors, hypotensive agents |
| 08/05/1997 | US5654325 Melatonin derivatives for use in treating sleep disorders |
| 08/05/1997 | US5654323 2-nitrogen-containing functional group-halobenzothiazoles; analgesics; antiinflammatory and hypotensive agents; inhibitors of cytokines (including tumor necrosis factor) and phospholipase; septic shock |
| 08/05/1997 | US5654319 N-[(4-heteroaryl-1-piperidinyl)alkyl]-2,3-naphthalimides and related compounds and their therapeutic utility |
| 08/05/1997 | US5654314 Respiratory system disorders |
| 08/05/1997 | US5654310 Antiischemic agents |
| 08/05/1997 | US5654308 Prevent or treat disease due to insufficient choline function |
| 08/05/1997 | US5654306 Piperidine derivative and pharmaceutical composition |
| 08/05/1997 | US5654303 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 08/05/1997 | US5654302 Nervous system disorders; brain disorders |
| 08/05/1997 | US5654295 Therapeutic compositions |
| 08/05/1997 | US5654288 Stable NADH and NADPH compositions for sublingual administration |
| 08/05/1997 | US5654281 Inhibiting the development of tolerance to and/or dependence on an addictive substance |
| 08/05/1997 | US5654173 Secreted proteins and polynucleotides encoding them |
| 08/05/1997 | US5654002 Piroxicam tablets and production and process thereof |
| 08/05/1997 | US5653975 Implanting encapsulated cells capable of producing human growth factor or trophic factor for diffusion into the central nervous system; treatment of diabetes; anemia; hypoparathyroidism; parkinson's and alzheimer's disease |
| 08/05/1997 | US5653964 Dentinal desensitizing compositions |
| 08/03/1997 | CA2196392A1 Tetrahydroisoquinoline derivatives |
| 07/31/1997 | WO1997027299A1 Mammalian cx3c chemokine genes |
| 07/31/1997 | WO1997027297A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | WO1997027296A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | WO1997027220A2 Substrates and inhibitors for cysteine protease ich-1 |
| 07/31/1997 | WO1997027186A1 1-pyrazol-3-yl-ethyl-4-indol-3-yl-piperidine used as medicine acting on the central nervous system |
| 07/31/1997 | WO1997027185A1 Piperidone tachykinin antagonists |
| 07/31/1997 | WO1997027177A2 Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 07/31/1997 | WO1997027176A1 Optical resolution of methylphenidate by 0,0'-bisaroyl tartaric acids |
| 07/31/1997 | WO1997026901A1 Regeneration of nerves in the central nervous system |
| 07/31/1997 | WO1997026894A1 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution |
| 07/31/1997 | WO1997026866A2 Preparations of non-steroidal analgesics |
| 07/31/1997 | WO1997026853A2 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | WO1997026790A1 APOPTOSIS INDUCED BY SHIGELLA IpaB |
| 07/31/1997 | DE19602971A1 New morphine derivatives |
| 07/31/1997 | DE19602970A1 New morphine derivatives |
| 07/31/1997 | DE19602969A1 New morphine derivatives |
| 07/31/1997 | DE19602968A1 New morphine derivatives |
| 07/31/1997 | DE19602965A1 New morphine derivatives |
| 07/31/1997 | DE19602964A1 New morphine derivatives |
| 07/31/1997 | DE19602963A1 New morphine derivatives |
| 07/31/1997 | DE19602962A1 New morphine derivatives |
| 07/31/1997 | DE19602961A1 New morphine derivatives |
| 07/31/1997 | DE19602960A1 New morphine derivatives |
| 07/31/1997 | DE19602959A1 New morphine derivatives |
| 07/31/1997 | DE19602505A1 1-(Pyrazol-4-Indol-3-yl)-Piperidine 1- (pyrazol-4-Indol-3-yl) -piperidines |
| 07/31/1997 | CA2244900A1 Regeneration of nerves in the central nervous system |
| 07/31/1997 | CA2244136A1 1-pyrazol-3-yl-ethyl-4-indol-3-yl-piperidine used as medicine acting on the central nervous system |
| 07/31/1997 | CA2243497A1 Substrates and inhibitors for cysteine protease ich-1 |
| 07/31/1997 | CA2242960A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | CA2242595A1 Optical resolution of methylphenidate by 0,0'-bisaroyl tartaric acids |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/30/1997 | EP0786520A1 Method for the production of biological active beta-NGF by genetic engineering |
| 07/30/1997 | EP0786450A2 Process for the preparation of O-demethyltramadol enantiomers |
| 07/30/1997 | EP0786000A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 07/30/1997 | EP0785944A1 Acyl amino acetamide derivatives with agonist activity for cck-a receptors |
| 07/30/1997 | EP0785938A1 Fused pyrrolocarbazoles |
| 07/30/1997 | EP0785933A1 Indole derivatives as 5ht1-like agonists |
| 07/30/1997 | EP0785932A1 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists |
| 07/30/1997 | EP0785926A1 New carboxylic acid derivatives, their preparation and their use |
| 07/30/1997 | EP0785793A1 Allosteric modulators of the nmda receptor |
| 07/30/1997 | EP0785788A1 Use of cck-b receptor antagonists for the treatment of sleep disorders |
| 07/30/1997 | EP0785785A1 Methods of inhibiting conditions associated with neuropeptide y |
| 07/30/1997 | EP0785781A2 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation |
| 07/30/1997 | EP0785778A1 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
| 07/30/1997 | EP0636146B1 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
| 07/30/1997 | EP0482183B1 Histamine h3-receptor agonist compounds for therapeutic use, pharmaceutical compositions acting as agonists of said receptor and method of preparation |
| 07/30/1997 | EP0476044B1 Use of IGF1 or IGF2 for the manufacture of a medicament in the treatment of amyotrophic lateral sclerosis |
| 07/30/1997 | CN1155886A Salts of an anti-migraine indole derivative |
| 07/30/1997 | CN1155842A Novel composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods |
| 07/30/1997 | CN1155838A Indolinone compounds for the treatment of disease |
| 07/30/1997 | CN1155546A Aminomethyl-2,3,8,9-tetrahydro-7H-1,4-dioxino£2,3-e|-indol-8-ones and derivatives |
| 07/30/1997 | CN1155432A Qindusutailing, medicine against virus |
| 07/30/1997 | CN1155431A Medical spirit for encephalic health and the preparation thereof |
| 07/30/1997 | CN1155417A Oral formulations of S(+)-ibuprofen |
| 07/29/1997 | US5652368 1,2,3,4-tetrahydroquinoline 2,3,4-trione-3 or 4-oximes |
| 07/29/1997 | US5652271 Therapeutic agents |
| 07/29/1997 | US5652269 Substituted hydrazinecarboximidamides and methods of use thereof |
| 07/29/1997 | US5652264 Cyclohexadiene derivatives useful in the treatment of depression |
| 07/29/1997 | US5652259 Administering 3-aroyl-2-arylbenzo(b)thiophene derivatives |
| 07/29/1997 | US5652252 Potassium channel activators |
| 07/29/1997 | US5652251 6-amino-1,4-dihydropyridine compounds as medicaments for treatment of the central nervous system, and processes for their preparation |
| 07/29/1997 | US5652248 Administering eliprodil along with an anticancer agent |
| 07/29/1997 | US5652246 Neurokinin receptor antagonists; nervous system disorders |
| 07/29/1997 | US5652245 Heterocyclic amines having central nervous system activity |
| 07/29/1997 | US5652243 Modulating cellular response |
| 07/29/1997 | US5652241 Antipsychotic agents, analgesics |
| 07/29/1997 | US5652240 Psychological disorders; anxiolytic agents, antidepressants |
| 07/29/1997 | US5652239 Treatment of strokes, ischemic attack, antagonists of excitatory amino acids glutamate and aspartate |
| 07/29/1997 | US5652214 Treating disorders by application of insulin-like growth factors and analogs |
| 07/29/1997 | US5652113 Contacting nonneuronal cells expressing on their cell surface the human serotonin receptor with chemical compound under conditions suitable for binding, detecting specific binding of compound to receptor |